Does Metformin Decrease Mortality in Patients with Type 2 Diabetes Mellitus Hospitalized for COVID-19? A Multivariable and Propensity Score-adjusted Meta-analysis

Zhiyuan Ma, Mahesh Krishnamurthy
doi: https://doi.org/10.1101/2022.04.03.22273353

Article Information

doi 
https://doi.org/10.1101/2022.04.03.22273353
History 
  • April 3, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Zhiyuan Ma1 and
  2. Mahesh Krishnamurthy1,*
  1. 1Department of Medicine, St Luke’s University Health Network-Easton Campus
  1. ↵*To whom correspondence should be addressed: Mahesh Krishnamurthy, MD, Department of Medicine, St Luke’s University Health Network-Easton Campus 250 S, 21st Street, Easton, PA 18042, Phone: 484-658-0692 Fax: 610-638-0757, Email: Mahesh.Krishnamurthy{at}sluhn.org
Back to top
Posted April 03, 2022.
Download PDF
Data/Code
Email
Does Metformin Decrease Mortality in Patients with Type 2 Diabetes Mellitus Hospitalized for COVID-19? A Multivariable and Propensity Score-adjusted Meta-analysis
Zhiyuan Ma, Mahesh Krishnamurthy
medRxiv 2022.04.03.22273353; doi: https://doi.org/10.1101/2022.04.03.22273353
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area